Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Häven hälsa AB
AB
Active
Org 5594734120
Malmvägen 16 A Lgh 1205
Medical specialists activities · NACE 8622
Est. 2024
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 2,8M
+375% vs 2024
EBITDA margin
45.8%
+132% vs 2024
Equity ratio
51.1%
Financial strength
Net profit 2025
SEK 745K
+69% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 2,8M
+375%
EBITDA
SEK 1,3M
+132%
Net profit
SEK 745K
+69%
Total assets
SEK 2M
+184%
Equity
SEK 1M
+115%
Employees
2
—
Company information
Legal name
Häven hälsa AB
Org number
5594734120
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 februari 2024
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget skall vara verksamt inom hälso- och sjukvård, utbildning såsom föreläsningar och handledning samt förvaltning av kapital.
Contact
Address
Malmvägen 16 A Lgh 1205
Email
golda.saadeh@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Sollentuna
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
1M
2024
3M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2024
1M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
593
2 818
Staff expenses
−4
−1 320
EBITDA
556
1 291
Depreciation & amort.
—
−37
EBIT
556
1 254
Net financials
1
2
Profit before tax
557
940
Tax
−115
−196
Net profit
441
745
Balance sheet
SEK thousands
Item
2024
2025
Total assets
690
1 961
Equity
466
1 001
Long-term debt
—
—
Short-term debt
224
644
Total debt
224
644
Financial ratios
5-year trend
EBITDA margin
45.8%
This company
15.8%
Market median
+190% vs market
2024
2025
Equity ratio
51.1%
This company
38.2%
Market median
+34% vs market
2024
2025
Return on equity
74.4%
This company
18.4%
Market median
+304% vs market
2024
2025
Net profit margin
26.4%
This company
8.1%
Market median
+226% vs market
2024
2025
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
2024
2025
Debt / equity
0.96×
This company
0.62×
Market median
+55% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-02-23 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
YS
Yazan Saliba
Deputy Board Member
2024
GS
Golda Saadeh
Board of Directors
2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Häven hälsa AB also hold positions in
0
other companies.
Person
Role here
Other companies
Yazan Saliba
Deputy Board Member
0 companies
Golda Saadeh
Board of Directors
0 companies